Join our third and final webinar of the series on the WHY, HOW, WHO, WHAT and WHEN of Regulatory Writing on Thursday 27 February 2025. This webinar will delve deeper into the various documents required for early development and highlight the importance of involving skilled regulatory and medical writers from a non-clinical and clinical development perspective.
Regulatory documents should be prepared for each new drug under development. Based on these documents, regulators will decide if clinical studies may be initiated and whether a drug will be approved for marketing. For each phase during drug development, different documents must be written.
We would love to address any specific questions you may have. Please share your questions with us by sending an email to getintouch@vennlife.com
Speaker: Arthur Noach
With a PhD on the border between toxicology and pharmaco-kinetics from Leiden University and registered as a pharmacist, Arthur joined Venn 25 years ago as a pharmacokinetics (PK) consultant and is a non-clinical senior consultant since 2000.
Arthur is a/an:
Key learnings:
Non-clinical and clinical aspects of regulatory writing, covering:
Note: The first and second webinar of this series is not a prerequisite to this final webinar. You can attend this webinar without having participated in the first and second sessions.
